- Home
- APLS vs RXO Comparison
APLS vs RXO Comparison
Compare APLS & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLS | RXO |
|---|---|---|
| Founded | 2009 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLS | RXO |
|---|---|---|
| Price | $23.62 | $14.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 15 |
| Target Price | ★ $33.11 | $16.33 |
| AVG Volume (30 Days) | 2.4M | ★ 2.5M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | $1,016,397,000.00 | ★ $5,940,000,000.00 |
| Revenue This Year | $29.00 | $27.93 |
| Revenue Next Year | N/A | $3.52 |
| P/E Ratio | $65.98 | ★ N/A |
| Revenue Growth | 42.11 | ★ 53.85 |
| 52 Week Low | $16.10 | $10.43 |
| 52 Week High | $35.72 | $29.60 |
Technical Indicators
Market Signals| Indicator | APLS | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 62.06 | 55.42 |
| Support Level | $20.51 | $12.83 |
| Resistance Level | $21.72 | $14.67 |
| Average True Range (ATR) | 0.81 | 0.70 |
| MACD | 0.51 | 0.47 |
| Stochastic Oscillator | 92.66 | 91.86 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.